Efficacy of telavancin in the treatment of methicillin-resistant Staphylococcus aureus osteomyelitis: Studies with a rabbit model

Journal of Antimicrobial Chemotherapy

Volumn 63, Issue 2, 2009, Pages 357-360

  Yin, Li Yan ^a   Calhoun, Jason H ^a   Thomas, Theodore S ^a   Wirtz, Eric D ^b  

^a University of Missouri   (United States)

^b TRIPLER ARMY MEDICAL CENTER   (United States)

Author keywords

Linezolid; Lipoglycopeptides; MRSA; Vancomycin

Indexed keywords

LINEZOLID; TELAVANCIN; VANCOMYCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBACTERIAL ACTIVITY; AREA UNDER THE CURVE; ARTICLE; BACTERIAL COUNT; BACTERIUM CULTURE; BACTERIUM ISOLATE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG HALF LIFE; MAXIMUM PLASMA CONCENTRATION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; OSTEOMYELITIS; RABBIT; TIBIA;

ACETAMIDES; AMINOGLYCOSIDES; ANIMALS; ANTI-BACTERIAL AGENTS; BONE MARROW; COLONY COUNT, MICROBIAL; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS; OSTEOMYELITIS; OXAZOLIDINONES; RABBITS; RANDOM ALLOCATION; STAPHYLOCOCCAL INFECTIONS; TREATMENT OUTCOME; VANCOMYCIN;

EID: 58849152238     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkn490     Document Type: Article

References (9)

1. Lew DP, Waldvogel FA. Osteomyelitis. Lancet 2004; 364: 369-79.
2. Sakoulas G, Moellering RC Jr. Increasing antibiotic resistance among methicillin-resistant Staphylococcus aureus strains. Clin Infect Dis 2008; 46 Suppl 5: S360-7.
3. Dombrowski JC, Winston LG. Clinical failures of appropriately-treated methicillin-resistant Staphylococcus aureus infections. J Infect 2008; 57: 110-5.
4. Nannini EC, Stryjewski ME. A new lipoglycopeptide: Telavancin. Expert Opin Pharmacother 2008; 9: 2197-207.
5. Attwood RJ, Laplante KL. Telavancin: A novel lipoglycopeptide antimicrobial agent. Am J Health Syst Pharm 2007; 64: 2335-48.
6. An YH, Kang QK, Arciola CR. Animal models of osteomyelitis. Int J Artif Organs 2006; 29: 407-20.
7. Norden CW. Experimental osteomyelitis. I. A description of the model. J Infect Dis 1970; 122: 410-8.
8. Wilson KJ, Mader JT. Concentrations of vancomycin in bone and serum of normal rabbits and those with osteomyelitis. Antimicrob Agents Chemother 1984; 25: 140-1.
9. Gotfried MH, Shaw JP, Benton BM et al. Intrapulmonary distribution of intravenous telavancin in healthy subjects and effect of pulmonary surfactant on in vitro activities of telavancin and other antibiotics. Antimicrob Agents Chemother 2008; 52: 92-7.